Becker's Healthcare July 11, 2018
Jessica Kim Cohen

Partnerships between healthcare organizations and technology giants will propel the global life sciences market to $1.5 trillion by 2022, according to a Frost & Sullivan report.

Advancements in healthcare digitization, healthcare consumerism, big data analytics and value-based care reimbursement models will help push the industry toward the $1.5 trillion milestone, according to the market research company.

Many of these trends sit at the intersection of healthcare and technology, with pharmaceutical researchers deploying artificial...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Analytics, Big Data, Biotechnology, Cloud, Digital Health, Market Research, Patient / Consumer, Payment Models, Pharma, Precision Medicine, Technology, Trends, Value Based
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Tessera trims workforce in shift to clinic
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise?
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs

Share This Article